Interhospital Variation in Admissions Managed With Critical Care Therapies or Invasive Hemodynamic Monitoring in Tertiary Cardiac Intensive Care Units: An Analysis From the Critical Care Cardiology Trials Network Registry.
Jan 5, 2024DOI: 10.1161/circoutcomes.123.010092Journal ArticleAHA
Written by: Sarah DonnellyChristopher F BarnettErin A BohulaSunit-Preet ChaudhryMeshe D ChondeHoward A CooperLori B DanielsMark W DodsonDaniel GerberMichael J GoldfarbJianping GuoMichael C KontosShuangbo LiuAdriana C LukVenu MenonConnor G O'BrienAlexander I PapolosBarbara A PisaniBrian J PotterRajnish PrasadGregory SchnellKevin S ShahLakshmi SridharanDerek Y F SoJeffrey J TeutebergWayne J TymchakSammy ZakariaJason N KatzDavid A MorrowSean van Diepen
Find these authors on Roon
SC
Dr. Sunit-Preet Chaudhry
Advanced Heart Failure · Ascension St. Vincent Hospital
CO
Dr. Connor O'Brien
Cardiac Critical Care · UCSF Medical Center
KS
Dr. Kevin Shah
Advanced Heart Failure · MemorialCare
Summary
BACKGROUND: Wide interhospital variations exist in cardiovascular intensive care unit (CICU) admission practices and the use of critical care restricted therapies (CCRx), but little is known about the differences in patient acuity, CCRx utilization, and the associated outcomes within tertiary centers.METHODS: The Critical Care Cardiology Trials Network is a multicenter registry of tertiary and academic CICUs in the United States and Canada that captured consecutive admissions in 2-month periods between 2017 and 2022. This analysis included 17 843 admissions across 34 sites and compared interhospital tertiles of CCRx (eg, mechanical ventilation, mechanical circulatory support, continuous renal replacement therapy) utilization and its adjusted association with in-hospital survival using logistic regression. The Pratt index was used to quantify patient-related and institutional factors associated with CCRx variability.RESULTS: The median age of the study population was 66 (56-77) years and 37% were female. CCRx was provided to 62.2% (interhospital range of 21.3%-87.1%) of CICU patients. Admissions to CICUs with the highest tertile of CCRx utilization had a greater burden of comorbidities, had more diagnoses of ST-elevation myocardial infarction, cardiac arrest, or cardiogenic shock, and had higher Sequential Organ Failure Assessment scores. The unadjusted in-hospital mortality (median, 12.7%) was 9.6%, 11.1%, and 18.7% in low, intermediate, and high CCRx tertiles, respectively. No clinically meaningful differences in adjusted mortality were observed across tertiles when admissions were stratified by the provision of CCRx. Baseline patient-level variables and institutional differences accounted for 80% and 5.3% of the observed CCRx variability, respectively.CONCLUSIONS: In a large registry of tertiary and academic CICUs, there was a >4-fold interhospital variation in the provision of CCRx that was primarily driven by differences in patient acuity compared with institutional differences. No differences were observed in adjusted mortality between low, intermediate, and high CCRx utilization sites.
CO
Dr. Connor O'Brien
Cardiology · Cardiac Critical CareUniversity of California San Francisco Medical Centerconnor
